|New Investigator Programs|
ISEH continues to provide opportunities for new scientists to grow in their careers, including facilitating and mentoring relationships with established ISEH scientists.
Saturday, 23 August 2014
The New Investigator Committee is sponsoring an invited speaker session featuring Simón Méndez-Ferrer, Ph.D. from the National Cardiovascular Research Center (CNIC, Madrid, Spain).
Méndez-Ferrer’s research has connected the brain and signals that are released
from the nervous system to the bone marrow stroma. His Ph.D. in Neuroscience characterized neurotrophic properties of neural crest-derived cells. This
background made him interested in the neural regulation of hematopoiesis.
Working with Paul S. Frenette he showed that hematopoietic stem cell traffic is
regulated by circadian oscillations. His work also identified nestin+ mesenchymal
stem cells in the bone marrow and determined their crucial role in the
hematopoietic stem cell niche. Dr.
Méndez-Ferrer is an Assistant Professor at the National Cardiovascular Research
Center (CNIC, Madrid, Spain) and an Adjunct Assistant Professor at the Icahn
School of Medicine at Mount Sinai, New York. He is supported in part by an
International Early Career Scientist grant of the Howard Hughes Medical
Friday, 22 August 2014
Join an expert for breakfast. Save your seat with your preferred expert when you complete meeting registration. Below is a list of confirmed expert:
· Sean Morrison, UT Southwestern Medical Center, Texas - TABLE FULL
· Scott Armstrong, Memorial Sloan Kettering Cancer Center, New York - TABLE FULL
· George Daley, Harvard Stem Cell Institute and Boston Children’s Hospital - TABLE FULL
Terry Fox Laboratory, Vancouver.
Recipient of the 2014 ISEH Metcalf Award
Keio University, Japan.
Recipient of the 2014 ISEH Till and McCulloch Award
Passegue, UC San Francisco - TABLE FULL
Friday, 22 August 2014
Take the chance to socialize with other new investigators from
around the world during an evening of mingling and drinks at the Six Resto
Lounge at the Hyatt Regency Hotel. To participate, add the New
Investigator Mixer to your meeting registration for the small
additional cost of $25.00 (USD). Tickets include 1 hour of light snacks and drinks.
Session 1: Alternative Careers
Interested in learning more about alternative careers in hematology and stem cells? Come meet experts in scientific funding, science editing, biotech, and pharma. An outstanding panel will share their experiences transitioning from academia to successful careers at CIHR, Cell Stem Cell, Stem Cell Technologies, and Jansen Pharmaceuticals. These sessions are highly interactive and informative, so come prepared to ask everything you wanted to know about life outside of academia.
Dr. Szilvassy began his career in the field of hematopoietic stem cell biology in 1985 as a Ph.D. student at the Terry Fox Laboratory in Vancouver. He then did his postdoctoral training at the Walter & Eliza Hall Institute in Melbourne, after which he returned to the USA to work as a scientist at a mid-size biotechnology company. This was followed by 7 years as a tenured Associate Professor of Medicine at the University of Kentucky, 9 years as Principal Scientist in Hematology/Oncology at Amgen, the world's largest biotechnology company, and finally his present position as Director of Hematopoietic Product R&D at STEMCELL Technologies.
Dr. Nicolay Ferrari completed his graduate studies at the Université de Montréal in 1999. He then pursued his post-doctoral work at the Dana-Farber Cancer Institute of the Harvard Medical School (Boston MA) and at the National Cancer Institute of the National Institutes of Health (Bethesda MD) developing anti-angiogenic gene therapy approaches and the use of neuronal stem cells as delivery vehicles of therapeutic genes for the treatment of brain tumors. Dr. Ferrari recently completed a Graduate Diploma in Management and Business from McGill in 2012. Following his postdoctoral studies, he spent 12 years in the biotechnology sector, first at Celmed Biosciences as Group Leader and then at Topigen Pharmaceuticals. At Topigen, as Director Pharmacology, he provided leadership for discovery and preclinical research activities that lead to the development of three novel anti-inflammatory drug candidates for the treatment of respiratory diseases, one currently in Phase 2 for the treatment of asthma. Since 2011, Dr. Ferrari is a Lecturer at the Department of Pharmacology at the Université de Sherbrooke. Just prior to joining the Canadian Critical Care Trial Group as the Executive Director in 2013, Dr. Ferrri was the Assistant Director of the Institute of Cancer Research of the Canadian Institutes of Health Research where he assisted the development of novel funding opportunities and public-private partnerships.
Dr. Sheila Chari - Cell Press
Dr. Sheila Chari completed her undergraduate studies in biology at the University of Illinois at Urbana-Champaign before moving to Chicago for graduate school at Northwestern University Feinberg School of Medicine. After completing a Ph.D studying transcriptional regulation of T cell development and leukemia, she joined the lab of Dr. Bruce Lahn at the University of Chicago to pursue postdoctoral studies in epigenetic regulation of cancer and somatic cell reprogramming. In 2012, she joined Cell Press as Reviews Editor with Cell Stem Cell. She is currently an Associate Editor with the journal.
Session 2: Omics: A Practical Guide
Sunday, 24 August 2014
Performing omics analysis on small cell populations is a major challenge for hematology and stem cell researchers. Come meet the scientists in the trenches of cutting edge omics in our field. This session is aimed at answering all your practical questions on performing various high-throughput sequencing techniques from the scientists developing the protocols for the study of hematopoietic stem cells and other rare cell populations.